Group One Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$554K Buy
+37,180
New +$828K ﹤0.01% 3246
2025
Q3
Sell
-14,699
Closed -$88.3K 8922
2025
Q2
$62.6K Buy
14,699
+2,500
+20% +$11.1K ﹤0.01% 5386
2025
Q1
$45.9K Buy
+12,199
New +$61.4K ﹤0.01% 5238
2024
Q1
Sell
-35,989
Closed -$464K 7714
2023
Q4
$505K Buy
+35,989
New +$484K ﹤0.01% 3061
2022
Q3
Sell
-1,006
Closed -$4.27K 8030
2022
Q2
$4K Hold
1,006
﹤0.01% 7209
2022
Q1
$4K Hold
1,006
﹤0.01% 7553
2021
Q4
$9K Buy
+1,006
New +$20.8K ﹤0.01% 7407

Other funds holding OLMA

Group One Trading's OLMA Position: Q1 2026 in Review

Group One Trading opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 37,180 shares worth $554K. The stake represents ﹤0.01% of the portfolio and ranks #3246 among its holdings. This is a return to the name: Group One Trading previously reported a position in OLMA as recently as Q2 2025.

Group One Trading first reported a position in OLMA in Q4 2021 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Group One Trading held 37,180 shares of Olema Pharmaceuticals worth $554K as of Q1 2026.
  • Olema Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3246 holding.
  • Group One Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.